Search Results - "Diaz, Sofia Silva"

Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting by Martínez-Lago, Nieves, Chucla, Teresa Calleja, De Castro, Beatriz Alonso, Ponte, Rafael Varela, Rendo, Cristina Reboredo, Rodriguez, Martin Igor Gomez-Randulfe, Diaz, Sofia Silva, Suarez, Begoña Graña, de la Cámara Gomez, Juan, Fernández, Fernando Busto, Salvador, María Mateos, Lopez, Margarita Reboredo

“…We evaluated the efficacy and safety of trifluridine/tipiracil (TAS-102) plus bevacizumab in treating refractory metastatic colorectal cancer (mCRC) in a…”
Get full text

Identification of patients with metastatic urothelial cancer not able to receive maintenance avelumab by Jackson-Spence, Francesca, Chauhan, Vishwani, Silva Diaz, Sofia, Gurung, Ayushma, Young, Matthew Nicholas, Nally, Elizabeth, Wells, Connor, Szabados, Bernadett, Powles, Thomas

“…702 Background: Maintenance avelumab following frontline platinum-based chemotherapy for metastatic urothelial cancer (mUC) is associated with survival…”
Get full text

Efficacy of carboplatin-etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis by Gomez-Randulfe, Igor, Silva Díaz, Sofía, Escriu, Carles, Mohammed, Saara, Shah, Riyaz, Benitez Fuentes, Javier David, Cox, Samantha, Monaca, Federico, Bria, Emilio, García-Campelo, María Rosario, Crook, Benjamin, Talbot, Toby, Leporati, Rita, Balachandran, Kirsty, Newsom-Davis, Tom, Hughes, Sarah, Cove-Smith, Laura, Taylor, Paul, Blackhall, Fiona, Califano, Raffaele

“…Second-line treatment for small-cell lung cancer (SCLC) is primarily guided by the time elapsed since the last platinum dose. Rechallenge with carboplatin and…”
Get full text

Standardization of data collection in the initial medical history: Implementation of an improvement plan in an oncology department by Gómez-Randulfe Rodríguez, Martín Igor, Alonso-Jáudenes Curbera, Guillermo, Alonso de Castro, Beatriz, Silva Diaz, Sofia, Parajó Vázquez, Iria, Campelo, Rosario Garcia

“…306 Background: Non-standardized data collection in medical records has a negative impact on the quality of care: it increases the possibility of medical…”
Get full text

Improving quality of care by standardising patient data collection in electronic medical records in an oncology department in Spain by Alonso-Jáudenes Curbera, Guillermo, Gómez-Randulfe Rodríguez, Martín Igor, Alonso de Castro, Beatriz, Silva Díaz, Sofía, Parajó Vázquez, Iria, Gratal, Paula, López López, Rafael, García Campelo, Rosario

“…BackgroundEvaluation of quality of care in oncology is key in ensuring patients receive adequate treatment. American Society of Clinical Oncology’s (ASCO)…”
Get full text

Effect of Tabernero's prognostic subgroups or development of neutropenia on survival outcomes of patients with refractory metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil plus bevacizumab (TASBEV) in real-world practice by Martinez-Lago, Nieves P., Alonso de Castro, Beatriz, Reboredo Rendo, Cristina, Calleja, Teresa, Gómez-Randulfe Rodríguez, Martín Igor, Silva Diaz, Sofia, Parajó Vázquez, Iria, Mateos Salvador, Maria, Busto Fernandez, Fernando, Grana Suarez, Begona, De la camara, Juan, Reboredo Lopez, Margarita

“…99 Background: TASBEV, compared with TAS-102, was associated with an improvement in progression-free survival (PFS) with tolerable toxicity in a randomized,…”
Get full text

Abstract B013: Novel prognostic score for patients with metastatic bladder cancer on immunotherapy by Chauhan, Vishwani, Diaz, Sofia Silva, Jara, Pablo, Efovi, Denis, Gurung, Ayushma, Young, Matthew, Wells, Connor, Nally, Elizabeth, Szabados, Bernadett, Powles, Thomas, Jackson-Spence, Francesca

“…Abstract Background: Some patients with metastatic bladder cancer (mBC) have durable responses to immune checkpoint inhibitors (ICIs); others progress early…”
Get full text

Abstract PO2-01-07: Real-world efficacy of dual HER2-blockade in combination with anthracycline-containing and anthracycline-free neoadjuvant treatment in early breast cancer (BC) by de Castro, Beatriz Alonso, Reboredo, Cristina, Calvo, Lourdes, Perez-Lopez, Maria-Eva, Rodriguez, Martin Igor Gomez Randulfe, diaz, Sofia silva, Vazquez, Iria Parajo, Novoa, Silvia Antolin

“…Abstract BACKGROUND: Neoadjuvant therapy with antiHER-2 blockade is the standard of care for HER-2 positive early BC. The objective of this treatment is tumor…”
Get full text

Abstract PO4-11-08: Risk of second malignancies in breast cancer patients. A population-based retrospective cohort study between 2010-2020 by Rama, Guadalupe, Perez-Lopez, Maria-Eva, Novoa, Silvia Antolin, Reboredo, Cristina, Alonso, Beatriz, Diaz, Sofia Silva, Graña, Begoña, Calvo, Lourdes, Garcia-Caballero, Tomas

“…Abstract Introduction: Breast cancer survivors live longer due to early detection programs and therapeutic advances. Staging and molecular classification are…”
Get full text

Abstract P4-07-39: NEOADYUVANT TREATMENT IN THE COVID ERA by de Castro, Beatriz Alonso, Rodriguez, Igor Gomez-Randulfe, Diaz, Sofia Silva, Reboredo, Cristina, Novoa, Silvia Antolin, Lopez, Eva Perez, Cordeiro, Patricia, Lesta, Rocio, Vazquez, Iria Parajo, Calvo, Lourdes

“…Abstract Since Coronavirus Disease 2019 (COVID-19) was declared pandemic in March 2020, there have been 545.226.550 cases up to 4 July 2022 (1). Several…”
Get full text